The Effectiveness of Retinalamin® Administered by Various Intramuscular Injection Timings in the Treatment of Patients with the Dry Form of Age- Related Macular Degeneration

The paper presents the evaluation of Retinalamin efficacy administered intramuscularly to 90 patients (180 eyes) aged 47 to 75 (averagely, 65.9 ± 7.18 years) with various stages of dry age-related macular degeneration (AMD) once or twice in 6 months. The data of multifocal electroretinography (MfERG...

Descripció completa

Dades bibliogràfiques
Autors principals: V. V. Neroev, O. V. Zaitseva, T. D. Okhotsimskaya, I. V. Tsapenko, E. P. Lantukh
Format: Article
Idioma:Russian
Publicat: Real Time Ltd 2018-10-01
Col·lecció:Российский офтальмологический журнал
Matèries:
Accés en línia:https://roj.igb.ru/jour/article/view/7